This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
antibody
product name :
TM7SF2 Polyclonal Antibody
catalog :
PA5-110492
quantity :
100 uL
price :
US 454.00
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human, mouse
application :
western blot, ELISA
product information
Product Type :
Antibody
Product Name :
TM7SF2 Polyclonal Antibody
Catalog # :
PA5-110492
Quantity :
100 uL
Price :
US 454.00
Clonality :
Polyclonal
Purity :
Affinity Chromatography
Host :
Rabbit
Reactivity :
Human, Mouse
Applications :
ELISA: 1 ug/mL, Western Blot: 1:500-1:2,000
Species :
Human, Mouse
Isotype :
IgG
Storage :
-20 C, Avoid Freeze/Thaw Cycles
Description :
TM7SF2 is involved in the conversion of lanosterol to cholesterol.
Immunogen :
Recombinant fusion protein containing a sequence corresponding to amino acids 160-250 of human TM7SF2 (NP_003264.2).
Format :
Liquid
Applications w/Dilutions :
ELISA: 1 ug/mL, Western Blot: 1:500-1:2,000
Aliases :
3110041O18Rik; 3-beta-hydroxysterol Delta (14)-reductase; ANG1; Another new gene 1 protein; C-14 sterol reductase; C14SR; delta(14)-sterol reductase; Delta(14)-sterol reductase TM7SF2; delta(14)-sterol reductase TM7SF2; delta(14)-sterol reductase; delta-14-SR; Dhcr14; DHCR14A; NET47; Putative sterol reductase SR-1; sterol C14-reductase; Tm7sf2; Transmembrane 7 superfamily member 2
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments